No black box warning on record for Imipramine Pamoate

As of the latest FDA labeling reviewed, Imipramine Pamoate (IMIPRAMINE PAMOATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Imipramine Pamoate medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Clinical Worsening and Suicide Risk Patients with major depressive disorder (MDD), both adult and pediatric, may experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality) or unusual changes in behavior, whether or not they are taking antidepressant medications, and this risk may persist until significant remission occurs. Suicide is a kn

No black box warning on record for Imipramine Pamoate

Other warnings & precautions

WARNINGS Clinical Worsening and Suicide Risk Patients with major depressive disorder (MDD), both adult and pediatric, may experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality) or unusual changes in behavior, whether or not they are taking antidepressant medications, and this risk may persist until significant remission occurs. Suicide is a kn

Imipramine Pamoate Black Box Warning

No black box warning on record for Imipramine Pamoate

Other warnings & precautions

Imipramine Pamoate Black Box Warning

No black box warning on record for Imipramine Pamoate

Other warnings & precautions